论文部分内容阅读
目的了解河南省结核菌耐多药筛查状况,为改进结核菌耐多药筛查防治措施提供依据。方法应用《中国疾病预防控制信息系统》中《结核病管理信息系统》河南省2014年1月1日-2016年9月30日报告的结核菌耐多药筛查数据资料,导出Excel数据库,应用χ~2检验的方法进行统计学分析。结果 2014年、2015年、2016年耐多药筛查率分别为24.16%、34.14%、27.46%,三年间耐多药筛查率差异有统计学意义(χ~2=361.5,P<0.001);2014年、2015年、2016年初治耐多药筛查率分别为23.20%、32.20%、25.97%,三年间初治耐多药筛查率差异有统计学意义(χ~2=382.9,P<0.001);2014年、2015年、2016年复治耐多药筛查率分别为34.90%、56.80%、45.90%,三年间复治耐多药筛查差异有统计学意义(χ~2=112.87,P<0.001)。结论复治耐多药筛查率距国家目标差距较大,河南省结核菌耐多药筛查率2015年明显偏高,和政府重视程度有关。应加大政府重视程度,建立长效工作机制,保持耐多药筛查工作达到规划目标。
Objective To understand the status of multidrug-resistant screening of tuberculosis in Henan Province and provide basis for improving the multi-drug screening and prevention measures of tuberculosis. Methods The data of tuberculosis multidrug resistance screening reported in “Tuberculosis Management Information System” of “China Disease Prevention and Control Information System” from January 1, 2014 to September 30, 2016 in Henan Province were used to derive Excel database and apply χ ~ 2 test methods for statistical analysis. Results The multidrug resistance screening rates in 2014, 2015 and 2016 were 24.16%, 34.14% and 27.46%, respectively. There was significant difference in MDR screening rate in three years (χ ~ 2 = 361.5, P <0.001) ; The screening rates of multidrug-resistant multi-drug in 2014, 2015 and 2016 were 23.20%, 32.20% and 25.97%, respectively, and there was significant difference in the multi-drug resistant screening rate in the three years (χ ~ 2 = 382.9, P <0.001). In 2014, 2015 and 2016, the rates of multi-drug resistant retreatment were 34.90%, 56.80% and 45.90% respectively. There was significant difference between the multidrug resistance multi-drug screening in three years (χ ~ 2 = 112.87, P <0.001). Conclusion The screening rate of multidrug-resistant multidrug-resistant retarder is far from the national target. The multidrug-resistant screening rate of TB in Henan Province is obviously higher in 2015, which is related to the degree of government attention. The government should pay more attention to the establishment of a long-term working mechanism to keep MDR screening up to the planning goal.